Skip to main content
. 2021 Aug 5;76:e3039. doi: 10.6061/clinics/2021/e3039

Table 1. Baseline characteristics of patients with overactive bladder included in the study (n=137) according to the randomized groups.

Characteristics One leg, once a week group (n=26) Two legs, once a week group (n=26) One leg, twice a week group (n=27) Two legs, twice a week group (n=28) Placebo group (n=30)
Age, years 58±9 62±9 62±7 62±10 60±11
Body mass index, kg/m2 26±6 30±6 29±7 29±4 29±5
Number of pregnancies 3.2±2.2 3.8±2.8 3.1±1.7 3.8±1.8 3.8±2.7
Post-menopause, n (%) 22 (85) 25 (96) 23 (85) 26 (93) 29 (97)
Sexually active, n (%) 12 (46) 8 (31) 8 (30) 11 (39) 12 (40)
Sedentary, n (%) 17 (65) 22 (85) 17 (63) 18 (64) 21 (70)
Married or with partner, n (%) 11 (42) 12 (46) 14 (52) 15 (54) 12 (40)
Educational level, n (%)
    <4 years 2 (8) 2 (8) 2 (7) 0 2 (7)
    4-8 years 16 (62) 15 (58) 19 (70) 13 (46) 15 (50)
    9-11 years 5 (19) 6 (23) 5 (19) 10 (36) 12 (40)
    ≥12 years 3 (12) 3 (12) 1 (4) 5 (18) 1 (3)
Frequency of initial urinary symptoms
    Daily urinary frequency 11.0±6.3 10.5±8.0 9.6±4.0 9.1±3.0 8.9±3.9
    Nocturia 1.9±1.3 1.8±1.6 2.8±2.2 2.0±1.3 2.6±1.9
    Urinary urgency 3.2±2.1 3.3±3.0 2.8±2.4 3.8±2.4 3.0±2.4
    Incontinence 1.8±1.5 2.8±2.5 2.0±1.6 2.2±1.8 2.6±2.2
Initial overactive bladder-V8 24.4 (20.2-28.7) 26.5 (20.5-31.0) 29.0 (16.5-32.0) 27.0 (24.5-31.0) 27.0 (22.0-31.7)

Overactive bladder-V8: Overactive Bladder Questionnaire in an abbreviated version. Initial urinary symptoms were collected from a specific voiding diary at the beginning of the treatment. Overactive bladder-V8 was collected using a questionnaire at the beginning of the treatment. Data are presented as means±standard deviations and medians (1st-3rd quartiles) unless otherwise indicated.